Vericred, Inc., launched a transparency tool for prescription drugs to help people more effectively manage their pharmaceutical benefit plans. Jane is quoted in the press release, saying, “With patients bearing more out-of-pocket costs for prescription drugs, the new personal health economics are compelling patients to become informed health consumers. These consumers need transparent, easy-to-use, helpful information on the price of prescription drugs and therapeutic alternatives.”
Jane quoted in Vericred press release on health consumers and prescription drugs
By Jane Sarasohn-Kahn on 18 May 2016 in
I'm grateful that Feedspot keeps track of the best public health websites and blogs, and that they named mine one of these. When you get a degree in public health, you become part of that community, so this list is especially valued by me. Thank you, Feedspot!
Each year, NCQA updates the HEDIS data set - and for 2023, the upgrade focuses on health equity and stratifying the right data for good. In my latest essay for Medecision (February 2023), I explore the new HEDIS upgrade, weaving in an insightful conversation I had with Michael L. Millenson, health care quality and accountability expert, along with great expectations for Techquity at VIVE 2023. Please check into this content which is super-timely in our post-pandemic health care world...
Jane continues to cross the Atlantic every few months to work with health/care stakeholders in the US, the EU and the UK. From mid-April to mid-July, I'll be spending most of the time on the Euro-side of the Pond collaborating with clients across the health/care ecosystem.